Empirical Finance, LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1572838
NEWTOWN SQUARE, PA
Position in VRTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,463,615
+$581,397 QoQ
Shares Held
8,986
+3.4% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#503
of 1,735 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Empirical Finance, LLC holds $8,529,315 across 6 Biotechnology names. VRTX ranks #1 (52.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
8,986 | $4,463,615 | |
| 2 | INCY |
Incyte Corp
|
12,461 | $1,412,578 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,482 | $924,086 | |
| 4 | PTCT |
Ptc Therapeutics, Inc.
|
9,226 | $752,564 | |
| 5 | MRNA |
Moderna, Inc.
|
9,426 | $660,102 | |
| 6 | TECH |
BIO-TECHNE Corp
|
4,478 | $316,370 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,463,615 | 8,986 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,882,218 | 8,694 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,949,218 | 8,711 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $3,717,838 | 9,493 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $4,009,471 | 9,006 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $4,337,199 | 8,946 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $3,548,995 | 8,813 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $4,146,653 | 8,916 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $4,090,050 | 8,726 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $3,900,869 | 9,332 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $3,669,334 | 9,018 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,119,227 | 8,970 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $2,852,230 | 8,105 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $2,258,106 | 7,167 | Shares | Sole | 2023-04-05 | |
| 2022-12-31 | $1,970,057 | 6,822 | Shares | Sole | 2023-02-21 | |
| 2022-09-30 | $1,817,442 | 6,277 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $1,477,988 | 5,245 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $1,297,542 | 4,972 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $975,463 | 4,442 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $591,875 | 3,263 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $534,117 | 2,649 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $569,243 | 2,649 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $626,064 | 2,649 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $594,037 | 2,183 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $492,946 | 1,698 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $352,641 | 1,482 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||